10-K Filing

NOVO INTEGRATED SCIENCES, INC. CIK: 1138978 FY 2022

Filing Information

Form Type	10-K
Accession Number	`0001493152-23-010679`
Period End Date	20220831
Filing Date	20230403
Fiscal Year	2022
Fiscal Period	FY
XBRL Instance	form10-k_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 101 Income Statement 48 Cash Flow Statement 89 Stockholders Equity 29

Balance Sheet 101 line items

Line Item	Tag	Value	Unit	Period
Convertible notes payable net of discount current	`DebtInstrumentUnamortizedDiscountCurrent`	$2.85M	USD	Point-in-time
Convertible preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Convertible preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$8.29M	USD	Point-in-time
Convertible preferred stock, shares authorized	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Convertible preferred stock, shares authorized	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.18M	USD	Point-in-time
Convertible preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$1.02M	USD	Point-in-time
Convertible preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$1.47M	USD	Point-in-time
Inventory, net	`InventoryNet`	$879.03K	USD	Point-in-time
Inventory, net	`InventoryNet`	$339.38K	USD	Point-in-time
Convertible preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Convertible preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Other receivables, current portion	`OtherReceivablesNetCurrent`	$814.16K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other receivables, current portion	`OtherReceivablesNetCurrent`	$1.09M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$571.34K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	499.00M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$218.38K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	499.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$11.13M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	26.61M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	31.18M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	1.16M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$5.73M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	1.76M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	26.61M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$5.80M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$6.07M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	31.18M	shares	Point-in-time
Common stock to be issued, shares	`CommonStockSharesSubscribedButUnissued`	4.15M	shares	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$32.03M	USD	Point-in-time
Common stock to be issued, shares	`CommonStockSharesSubscribedButUnissued`	3.62M	shares	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$18.84M	USD	Point-in-time
Right-of-use assets, net	`OperatingLeaseRightOfUseAsset`	$2.67M	USD	Point-in-time
Right-of-use assets, net	`OperatingLeaseRightOfUseAsset`	$2.54M	USD	Point-in-time
Other receivables, net of current portion	`LongTermInvestmentsAndReceivablesNet`	-	USD	Point-in-time
Other receivables, net of current portion	`LongTermInvestmentsAndReceivablesNet`	$692.74K	USD	Point-in-time
Goodwill	`Goodwill`	$7.83M	USD	Point-in-time
Goodwill	`Goodwill`	$636.94K	USD	Point-in-time
Goodwill	`Goodwill`	$9.49M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$61.96M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$40.87M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.45M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.80M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.12M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.13M	USD	Point-in-time
Accrued interest (including amounts to related parties)	`InterestPayableCurrent`	$454.19K	USD	Point-in-time
Accrued interest (including amounts to related parties)	`InterestPayableCurrent`	$366.28K	USD	Point-in-time
Government loans and notes payable, current portion	`NotesAndLoansPayableCurrent`	$4.49M	USD	Point-in-time
Government loans and notes payable, current portion	`NotesAndLoansPayableCurrent`	-	USD	Point-in-time
Convertible notes payable, net of discount of $2,851,048	`ConvertibleNotesPayableCurrent`	-	USD	Point-in-time
Convertible notes payable, net of discount of $2,851,048	`ConvertibleNotesPayableCurrent`	$9.10M	USD	Point-in-time
Contingent liability	`BusinessCombinationContingentConsiderationLiabilityCurrent`	$534.60K	USD	Point-in-time
Contingent liability	`BusinessCombinationContingentConsiderationLiabilityCurrent`	-	USD	Point-in-time
Due to related parties	`DueToRelatedPartiesCurrent`	$478.90K	USD	Point-in-time
Due to related parties	`DueToRelatedPartiesCurrent`	$478.92K	USD	Point-in-time
Finance lease liability, current portion	`FinanceLeaseLiabilityCurrent`	$23.18K	USD	Point-in-time
Finance lease liability, current portion	`FinanceLeaseLiabilityCurrent`	$8.89K	USD	Point-in-time
Operating lease liability, current portion	`OperatingLeaseLiabilityCurrent`	$582.09K	USD	Point-in-time
Operating lease liability, current portion	`OperatingLeaseLiabilityCurrent`	$530.80K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$14.07M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$8.46M	USD	Point-in-time
Debentures, related parties	`DueToRelatedPartiesNoncurrent`	$946.25K	USD	Point-in-time
Debentures, related parties	`DueToRelatedPartiesNoncurrent`	$982.21K	USD	Point-in-time
Government loans and notes payable, net of current portion	`NotesAndLoanPayableNonCurrent`	$5.13M	USD	Point-in-time
Government loans and notes payable, net of current portion	`NotesAndLoanPayableNonCurrent`	$161.46K	USD	Point-in-time
Finance lease liability, net of current portion	`FinanceLeaseLiabilityNoncurrent`	$16.22K	USD	Point-in-time
Finance lease liability, net of current portion	`FinanceLeaseLiabilityNoncurrent`	$12.08K	USD	Point-in-time
Operating lease liability, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$2.19M	USD	Point-in-time
Operating lease liability, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$2.06M	USD	Point-in-time
Deferred tax liability	`DeferredIncomeTaxLiabilitiesNet`	$1.45M	USD	Point-in-time
Deferred tax liability	`DeferredIncomeTaxLiabilitiesNet`	$1.50M	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$18.83M	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$18.15M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Convertible preferred stock; $0.001 par value; 1,000,000 shares authorized; 0 and 0 shares issued and outstanding at August 31, 2022 and August 31, 2021, respectively	`PreferredStockValue`	-	USD	Point-in-time
Convertible preferred stock; $0.001 par value; 1,000,000 shares authorized; 0 and 0 shares issued and outstanding at August 31, 2022 and August 31, 2021, respectively	`PreferredStockValue`	-	USD	Point-in-time
Common stock; $0.001 par value; 499,000,000 shares authorized; 31,180,603 and 26,610,144 shares issued and outstanding at August 31, 2022 and August 31, 2021, respectively	`CommonStockValue`	$31.18K	USD	Point-in-time
Common stock; $0.001 par value; 499,000,000 shares authorized; 31,180,603 and 26,610,144 shares issued and outstanding at August 31, 2022 and August 31, 2021, respectively	`CommonStockValue`	$26.61K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$66.06M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$54.58M	USD	Point-in-time
Common stock to be issued (4,149,633 and 3,622,199 shares at August 31, 2022 and August 31, 2021)	`CommonStockToBeIssued`	$9.47M	USD	Point-in-time
Common stock to be issued (4,149,633 and 3,622,199 shares at August 31, 2022 and August 31, 2021)	`CommonStockToBeIssued`	$9.24M	USD	Point-in-time
Other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$560.84K	USD	Point-in-time
Other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$991.08K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-20.97M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-53.82M	USD	Point-in-time
Total Novo Integrated Sciences, Inc. stockholders equity	`StockholdersEquity`	$43.86M	USD	Point-in-time
Total Novo Integrated Sciences, Inc. stockholders equity	`StockholdersEquity`	$22.31M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-60.26K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-257.59K	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$29.57M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$43.80M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$22.05M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$40.87M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$61.96M	USD	Point-in-time

Income Statement 48 line items

Line Item	Tag	Value	Unit	Period
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$9.31M	USD	Annual
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$11.74M	USD	Annual
Cost of revenues	`CostOfRevenue`	$5.48M	USD	Annual
Cost of revenues	`CostOfRevenue`	$6.94M	USD	Annual
Gross profit	`GrossProfit`	$4.80M	USD	Annual
Gross profit	`GrossProfit`	$3.82M	USD	Annual
Selling expenses	`SellingExpense`	$7.53K	USD	Annual
Selling expenses	`SellingExpense`	$20.70K	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$14.36M	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$8.09M	USD	Annual
Impairment of assets	`ImpairmentOfIntangibleAssetsFinitelived`	$14.08M	USD	Annual
Impairment of assets	`ImpairmentOfIntangibleAssetsFinitelived`	-	USD	Annual
Goodwill impairment	`GoodwillImpairmentLoss`	$1.36M	USD	Annual
Goodwill impairment	`GoodwillImpairmentLoss`	$99.35K	USD	Annual
Total operating expenses	`OperatingExpenses`	$29.83M	USD	Annual
Total operating expenses	`OperatingExpenses`	$8.20M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-25.03M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-4.37M	USD	Annual
Interest income	`InvestmentIncomeInterest`	$169.09K	USD	Annual
Interest income	`InvestmentIncomeInterest`	$45.69K	USD	Annual
Interest expense	`InterestExpenseDebtExcludingAmortization`	$1.59M	USD	Annual
Interest expense	`InterestExpenseDebtExcludingAmortization`	$165.00K	USD	Annual
Other income	`OtherNonoperatingIncomeExpense`	$21.90K	USD	Annual
Other income	`OtherNonoperatingIncomeExpense`	-	USD	Annual
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$5.97M	USD	Annual
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	-	USD	Annual
Foreign currency transaction losses	`ForeignCurrencyTransactionGainLossBeforeTax`	$-641.64K	USD	Annual
Foreign currency transaction losses	`ForeignCurrencyTransactionGainLossBeforeTax`	-	USD	Annual
Total other income (expense)	`NonoperatingIncomeExpense`	$-97.42K	USD	Annual
Total other income (expense)	`NonoperatingIncomeExpense`	$-8.04M	USD	Annual
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-4.47M	USD	Annual
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-33.07M	USD	Annual
Income tax expense	`IncomeTaxExpenseBenefit`	$-22.30K	USD	Annual
Income tax expense	`IncomeTaxExpenseBenefit`	-	USD	Annual
Net loss	`ProfitLoss`	$-4.47M	USD	Annual
Net loss	`ProfitLoss`	$-33.05M	USD	Annual
Net loss attributed to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-8.79K	USD	Annual
Net loss attributed to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-195.96K	USD	Annual
Net loss attributed to Novo Integrated Sciences, Inc.	`NetIncomeLoss`	$-32.85M	USD	Annual
Net loss attributed to Novo Integrated Sciences, Inc.	`NetIncomeLoss`	$-4.46M	USD	Annual
Foreign currency translation loss	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-210.23K	USD	Annual
Foreign currency translation loss	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-431.61K	USD	Annual
Comprehensive loss:	`ComprehensiveIncomeNetOfTax`	$-4.68M	USD	Annual
Comprehensive loss:	`ComprehensiveIncomeNetOfTax`	$-33.48M	USD	Annual
Weighted average common shares outstanding - basic and diluted	`WeightedAverageNumberOfSharesOutstandingBasic`	29.12M	shares	Annual
Weighted average common shares outstanding - basic and diluted	`WeightedAverageNumberOfSharesOutstandingBasic`	24.77M	shares	Annual
Net loss per common share - basic and diluted	`EarningsPerShareBasic`	$-0.18	USD	Annual
Net loss per common share - basic and diluted	`EarningsPerShareBasic`	$-1.13	USD	Annual

Cash Flow Statement 89 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-4.47M	USD	Annual
Net loss	`ProfitLoss`	$-33.05M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$3.02M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$1.72M	USD	Annual
Fair value of vested stock options	`FairValueOfVestedStockOptions`	$-155.50K	USD	Annual
Fair value of vested stock options	`FairValueOfVestedStockOptions`	$-426.69K	USD	Annual
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$1.33M	USD	Annual
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$875.17K	USD	Annual
Operating lease expense	`OperatingLeaseExpense`	$642.99K	USD	Annual
Operating lease expense	`OperatingLeaseExpense`	$852.58K	USD	Annual
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$5.97M	USD	Annual
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	-	USD	Annual
Foreign currency transaction losses	`ForeignCurrencyTransactionLossBeforeTax`	$641.64K	USD	Annual
Foreign currency transaction losses	`ForeignCurrencyTransactionLossBeforeTax`	-	USD	Annual
Gain on forgiveness of debt	`GainsLossesOnExtinguishmentOfDebt`	$21.90K	USD	Annual
Gain on forgiveness of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Impairment of assets	`ImpairmentOfIntangibleAssetsFinitelived`	$14.08M	USD	Annual
Impairment of assets	`ImpairmentOfIntangibleAssetsFinitelived`	-	USD	Annual
Other receivables write-off	`OtherReceivableWriteOffs`	$299.67K	USD	Annual
Other receivables write-off	`OtherReceivableWriteOffs`	-	USD	Annual
Goodwill impairment	`GoodwillImpairmentLoss`	$1.36M	USD	Annual
Goodwill impairment	`GoodwillImpairmentLoss`	$99.35K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-457.01K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-1.10M	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$527.40K	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$147.81K	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$369.65K	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$43.19K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$283.23K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-45.23K	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-287.03K	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$38.74K	USD	Annual
Accrued interest	`IncreaseDecreaseInInterestPayableNet`	$9.02K	USD	Annual
Accrued interest	`IncreaseDecreaseInInterestPayableNet`	$101.35K	USD	Annual
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$-806.39K	USD	Annual
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$-618.64K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.02M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-5.88M	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$255.95K	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$190.17K	USD	Annual
Cash paid for acquisition	`PaymentsToAcquireBusinessesGross`	$10.00K	USD	Annual
Cash paid for acquisition	`PaymentsToAcquireBusinessesGross`	-	USD	Annual
Cash acquired with acquisition	`CashAcquiredFromAcquisition`	$57.49K	USD	Annual
Cash acquired with acquisition	`CashAcquiredFromAcquisition`	$3.74M	USD	Annual
Amounts loaned for other receivables	`PaymentsForProceedsFromLoansReceivable`	$473.10K	USD	Annual
Amounts loaned for other receivables	`PaymentsForProceedsFromLoansReceivable`	-	USD	Annual
Collection of other receivable	`ProceedsFromCollectionOfOtherReceivables`	-	USD	Annual
Collection of other receivable	`ProceedsFromCollectionOfOtherReceivables`	$296.14K	USD	Annual
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$3.00M	USD	Annual
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$163.46K	USD	Annual
Receipts from (repayments to) related parties	`ProceedsFromRepaymentsOfRelatedPartyDebt`	$267.77K	USD	Point-in-time
Receipts from (repayments to) related parties	`ProceedsFromRepaymentsOfRelatedPartyDebt`	$-246.33K	USD	Annual
Receipts from (repayments to) related parties	`ProceedsFromRepaymentsOfRelatedPartyDebt`	$16.60K	USD	Annual
Repayments of notes payable	`RepaymentsOfNotesPayable`	$10.59M	USD	Annual
Repayments of notes payable	`RepaymentsOfNotesPayable`	$2.77M	USD	Annual
Repayments of finance leases	`FinanceLeasePrincipalPayments`	$18.43K	USD	Annual
Repayments of finance leases	`FinanceLeasePrincipalPayments`	$8.87K	USD	Annual
Proceeds from issuance of convertible notes	`ProceedsFromConvertibleDebt`	-	USD	Annual
Proceeds from issuance of convertible notes	`ProceedsFromConvertibleDebt`	$15.27M	USD	Annual
Repayment of convertible notes	`RepaymentsOfConvertibleDebt`	$5.10M	USD	Annual
Repayment of convertible notes	`RepaymentsOfConvertibleDebt`	-	USD	Annual
Proceeds from the sale of common stock, net of offering costs	`ProceedsFromIssuanceOfCommonStock`	$7.33M	USD	Annual
Proceeds from the sale of common stock, net of offering costs	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$12.00K	USD	Annual
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	-	USD	Annual
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$4.32M	USD	Annual
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-427.12K	USD	Annual
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$33.33K	USD	Annual
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$-65.74K	USD	Annual
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$6.23M	USD	Annual
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-6.11M	USD	Annual
CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$8.29M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$2.07M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$2.18M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, END OF YEAR	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$8.29M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, END OF YEAR	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$2.07M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, END OF YEAR	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$2.18M	USD	Point-in-time
Interest	`InterestPaidNet`	$144.99K	USD	Annual
Interest	`InterestPaidNet`	$1.50M	USD	Annual
Income taxes	`IncomeTaxesPaidNet`	-	USD	Annual
Income taxes	`IncomeTaxesPaidNet`	-	USD	Annual
Common stock issued for intangible assets	`StockIssued1`	-	USD	Annual
Common stock issued for intangible assets	`StockIssued1`	$876.00K	USD	Annual
Common stock issued for convertible debt	`CommonStockIssuedForConvertibleDebt`	-	USD	Annual
Common stock issued for convertible debt	`CommonStockIssuedForConvertibleDebt`	$1.27M	USD	Annual
Common stock issued for acquisition	`CommonStockIssuedForAcquisitionOfAssets`	$1.70M	USD	Annual
Common stock issued for acquisition	`CommonStockIssuedForAcquisitionOfAssets`	$430.84K	USD	Annual
Warrants issued with convertible notes	`WarrantsIssuedWithConvertibleNotes`	-	USD	Annual
Warrants issued with convertible notes	`WarrantsIssuedWithConvertibleNotes`	$5.55M	USD	Annual

Stockholders Equity 29 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$29.57M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$43.80M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$22.05M	USD	Point-in-time
Common stock issued for cash, net of offering costs	`StockIssuedDuringPeriodValueNewIssues`	$7.33M	USD	Annual
Common stock for services	`StockIssuedDuringPeriodValueIssuedForServices`	$1.33M	USD	Annual
Common stock for services	`StockIssuedDuringPeriodValueIssuedForServices`	$875.17K	USD	Annual
Common stock issued for acquisitions	`StockIssuedDuringPeriodValueAcquisitions`	$1.70M	USD	Annual
Common stock issued for acquisitions	`StockIssuedDuringPeriodValueAcquisitions`	$430.84K	USD	Annual
Common stock issued for intellectual property	`StockIssuedDuringPeriodValuePurchaseOfAssets`	$876.00K	USD	Annual
Common stock issued for intellectual property, shares	`StockIssuedDuringPeriodSharesPurchaseOfAssets`	36,222.00	shares	Point-in-time
Common stock to be issued for acquisitions	`CommonStockToBeIssuedForAcquisitions`	$1.43M	USD	Annual
Common stock to be issued for acquisitions	`CommonStockToBeIssuedForAcquisitions`	$9.24M	USD	Annual
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$12.00K	USD	Annual
Exercise of stock options, shares	`StockIssuedDuringPeriodSharesStockOptionsExercised`	-	shares	Annual
Exercise of stock options, shares	`StockIssuedDuringPeriodSharesStockOptionsExercised`	7,500.00	shares	Annual
Fair value of stock options	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$155.50K	USD	Annual
Fair value of stock options	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$426.69K	USD	Annual
Rounding due to stock split	`StockIssuedDuringPeriodValueStockSplits`	-	USD	Annual
Foreign currency translation loss	`OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToNoncontrollingInterest`	$-431.61K	USD	Annual
Foreign currency translation loss	`OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToNoncontrollingInterest`	$-210.23K	USD	Annual
Net loss	`ProfitLoss`	$-4.47M	USD	Annual
Net loss	`ProfitLoss`	$-33.05M	USD	Annual
Common stock issued as collateral and held in escrow	`CommonStockIssuedToBeHeldInEscrow`	-	USD	Annual
Common stock for conversion of convertible notes	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$1.27M	USD	Annual
Value of warrants issued with convertible notes	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$5.55M	USD	Annual
Issuance of common stock to be issued	`IssuanceOfCommonStockToBeIssuedValue`	-	USD	Annual
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$29.57M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$43.80M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$22.05M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.